|
Match
|
Document |
Document Title |
|
|
7604820 |
Solid preparation containing chitosan powder and process for producing the same
A colonic delivery solid preparation containing chitosan powder, which can control the dissolution of a medicament therefrom in the large intestine and release the medicament contained therein...
|
|
|
7576067 |
Pulsatile release compositions and methods for enhanced intestinal oligonucleotide drug absorption
Delayed release oral pharmaceutical formulations and methods for enhanced intestinal drug absorption. The formulation comprises a first population of carrier particles comprising a drug and a...
|
|
|
7563456 |
Process for preparation of programmed liberation composition with venlafaxine and the resulting product
Process for the preparation of programmed liberation compositions with venlafaxine and the resulting product, from which the resulting product allows a better absorption of the active principle and...
|
|
|
7553844 |
Methods for treatment of HIV or malaria using combinations of chloroquine and protease inhibitors
The present invention relates to a drug combination capable of conferring therapeutic benefits in the treatment of both AIDS and malaria. In particular, it relates to a drug combination including...
|
|
|
7510729 |
Combination of polyvinyl acetate with water-insoluble, acid-insoluble, or alkali-insoluble polymers used for the production of film coatings with highly controlled release and high stability
The invention relates to the combination of polyvinyl acetate and water-insoluble, acid-insoluble, or alkali-insoluble polymers used for producing film coatings for forms of administration in which...
|
|
|
7498038 |
Chitin microparticles and their medical uses
The present invention relates to chitin microparticles and their medical uses, in particular in the treatment of allergy, or the treatment of conditions that would benefit from an upregulation of...
|
|
|
7465462 |
Multiparticulate controlled release selective serotonin reuptake inhibitor formulations
A multiparticulate controlled release selective serotonin reuptate inhibitor (SSRI) formulation for oral administration is provided. The formulation includes particles of an SSRI or a...
|
|
|
7422758 |
Sustained release vitamin composition
A therapeutic formulation in the form of a beadlet, suitable for oral administration and adapted to provide immediate and sustained release of therapeutic material. Each beadlet comprises an...
|
|
|
7413781 |
Gels for encapsulation of biological materials
This invention provides novel methods for the formation of biocompatible membranes around biological materials using photopolymerization of water soluble molecules. The membranes can be used as a...
|
|
|
7413753 |
Calcium phosphate delivery vehicles for osteoinductive proteins
A composition for delivery of osteogenic proteins is disclosed. The composition comprises an osteogenic protein, a calcium phosphate material as a carrier, and an effective amount of an...
|
|
|
7413750 |
Process for producing solid oral dosage forms with sustained release of active ingredient
The present invention relates to a process for producing solid oral dosage forms with sustained release of active ingredient, comprising at least one active ingredient, a preformulated mixture of...
|
|
|
7338928 |
System for releasing encapsulated active ingredients
The present invention relates to a controlled release system that can be incorporated in cosmetic, personal care, and household products to effectively encapsulate wide range of active ingredients...
|
|
|
7338668 |
Drug carrier pellet production process
The invention provides a process for the production of drug carrier pellets comprising spray-drying a solution of a physiologically tolerable cellulosic binder containing a physiologically...
|
|
|
7316821 |
Stabilized controlled release substrate having a coating derived from an aqueous dispersion of hydrophobic polymer
A stabilized solid controlled release dosage form having a coating derived from an aqueous dispersion of ethylcellulose is obtained by overcoating a substrate including a therapeutically active...
|
|
|
7314640 |
Formulation and process for drug loaded cores
The present invention relates to a controlled release pellet of metoprolol and its pharmaceutically acceptable salts that uses a water soluble or a water swellable inert starting seed or core.
|
|
|
7309500 |
Microparticles
A method of forming particles, comprises accelerating a first stream comprising a first liquid, applying a charging voltage of at most 1.5 kV to the first stream, and vibrating the first stream, to...
|
|
|
7303767 |
Personal care compositions comprising coated/treated metal silicate absorbent particles
Coated particles of metal (such as calcium) silicate that exhibit excellent odor neutralization and sebum absorption properties when present within certain cosmetic and/or personal care...
|
|
|
7303766 |
Coated/treated metal silicate absorbent particles
Coated particles of metal (such as calcium) silicate that exhibit excellent odor neutralization and sebum absorption properties when present within certain cosmetic and/or personal care...
|
|
|
7297786 |
RNA interference in respiratory epitheial cells
The present invention is directed to small interfering RNA molecules targeted against a gene of interest in respiratory epithelial cells, and methods of using these RNA molecules.
|
|
|
7276253 |
Stable drug form for oral administration with benzimidazole derivatives as active ingredient and process for the preparation thereof
The invention relates to a stable medicament for oral administration which comprises
(a) a core which contains an active ingredient selected from Omeprazole, Lansoprazole and Pantoprazole,...
|
|
|
7270831 |
Orally administrable opioid formulations having extended duration of effect
Sustained release oral solid dosage forms of opioid analgesics are provided as multiparticulate systems which are bioavailable and which provide effective blood levels of the opioid analgesic for...
|
|
|
7255878 |
Stable benzimidazole formulation
A stable composition with a benzimidazole derivative, such as Omeprazole, which does not contain a separating layer between the active compound and an enteric coating layer. Instead, the enteric...
|
|
|
7252842 |
Induced phase transition method for the production of microparticles containing hydrophilic active agents
Microparticles and a method for their production is described. The process of the present invention provides a simple, quick, and efficient one-pot process for the production of microparticles...
|
|
|
7235261 |
Controlled release encapsulation
This invention relates to a controlled release encapsulated dry powder that is formed by an emulsion comprising: A) a fully hydrolyzed polymer, B) a hydrophobic silica, C) a modified corn starch,...
|
|
|
7223421 |
Teste masked pharmaceutical particles
Taste masked particles and chewable tablets made therefrom are disclosed. The taste masked particles comprise a core containing an active ingredient and a polymeric coating covering said core, said...
|
|
|
7220433 |
Compositions for parenteral administration and sustained-release of therapeutic agents
The present invention is directed to parenterally-administrable microparticles for providing sustained-release of a therapeutic agent in the body, where the microparticles include a polymeric core...
|
|
|
7195769 |
Pharmaceutical compositions of anti-tubercular drugs and process for their preparation
A pharmaceutical composition of anti-tubercular drugs for oral use comprising Rifampicin and/or Isoniazid wherein the bioavailability of Rifampicin and/or other drugs is enhanced. Preferably the...
|
|
|
7189416 |
Method for stable and controlled delivery of (-)-hydroxycitric acid
A method for making the potassium, sodium and other hygroscopic salts of (−)-hydroxycitric acid and mixtures thereof workable by initial treatment with a desiccating agent, such as fumed silicon...
|
|
|
7166305 |
Polyvalent metal-substituted starch products
Improved starch-metal derivatives are provided which have excellent dry flow characteristics and ready dispersability in hot or cold water. The preferred derivatives comprise granules of starch...
|
|
|
7101576 |
Nanoparticulate megestrol formulations
The present invention is directed to nanoparticulate compositions comprising megestrol. The megestrol particles of the composition have an effective average particle size of less than about 2000 nm.
|
|
|
7101573 |
Simethicone solid oral dosage form
The present invention provides a composition for forming a compressed solid dosage form that is a free-flowing compressible admixture of simethicone, an adsorbant, and an optional active agent,...
|
|
|
7081256 |
Quinolinone derivative pharmaceutical compositon and production method therefor
A quinolinone derivative pharmaceutical composition comprising a quinolinone derivative represented by the structural formula (I):
wherein the quinolinone derivative is in the form of...
|
|
|
7074430 |
Controlled release tramadol tramadol formulation
A controlled release preparation for oral administration contains tramadol, or a pharmaceutically acceptable salt thereof, as active ingredient.
|
|
|
7056534 |
Coated potassium chloride granules and tablets
This invention provides extended release potassium chloride granules consisting essentially of potassium chloride crystals having a mesh size of about 20–60 mesh that are coated only with...
|
|
|
7052716 |
Cosmetic and dermatological preparations comprising an effective content of bile acids, their salts and/or their derivatives
Cosmetic and dermatological preparations having an effective content of bile acids, their salts and/or their derivatives, it being possible for said active ingredients to be present either...
|
|
|
7048948 |
Stable granulates containing S-adenosylmethionine and process for the preparation thereof
A fluid bed granulation process for manufacturing non-hygroscopic, stable granulates containing a water-soluble salt of S-adenosylmethionine is described. Said process comprises:
a) the...
|
|
|
7045146 |
Templating of solid particles by polymer multilayers
Process for encapsulation of an uncharged crystalline solid particle include treating the crystalline solid particle material with amphiphilic substances and subsequently coating the material with...
|
|
|
7022663 |
Oral, nasal and pulmonary dosage formulations of copolymer 1
Pharmaceutical compositions useful for treating autoimmune diseases in a mammal comprising as an active ingredient a therapeutically effective amount of Copolymer 1, and microcrystalline cellulose...
|
|
|
7011849 |
Second release phase formulation
Formulations are provided herein which allow for a once daily dosing regimen for amoxicillin and clavulanic acid.
|
|
|
7008646 |
Cubic liquid crystalline compositions and methods for their preparation
A dry powder cubic gel precursor comprising an encapsulating compound, an amphiphile capable of forming a cubic liquid crystalline phase, and optionally a solvent. The encapsulating compound (A),...
|
|
|
6994873 |
Multiparticulate formulations of lithium salts for oral administration suitable for once-a-day administration
This invention refers to:
multiparticulate formulations of Lithium salts for oral administration constituted by either modified release granules or mixtures of modified and conventional...
|
|
|
6991807 |
Antibiotic composition
Disclosed are antibiotic products for delivering at least two different antibiotics, wherein the products are comprised of at least three or four dosage forms with different release profiles and...
|
|
|
6989159 |
Pharmaceutical compositions containing lithium carbonate
Once daily pharmaceutical compositions containing lithium carbonate in the form of coated granules.
|
|
|
6984404 |
Methods for preparing coated drug particles and pharmaceutical formulations thereof
Disclosed are methods using pulsed laser ablation to prepare coated drug particles of uniform size and thickness. The coated drug particles ranged in size from several nanometers to several...
|
|
|
6974593 |
Insoluble drug delivery
Particles of water insoluble biologically active compounds, particularly water-insoluble drugs, with an average size of 100 nm to about 300 nm, are prepared by dissolving the compound in a solution...
|
|
|
6974592 |
Encapsulated agglomeration of microcapsules and method for the preparation thereof
Microcapsules comprising an agglomeration of primary microcapsules, each individual primary microcapsule having a primary shell and the agglomeration being encapsulated by an outer shell, may be...
|
|
|
6969530 |
Microcapsules and emulsions containing low bloom gelatin and methods of making and using thereof
Described herein are microcapsules and emulsions prepared from low Bloom gelatin and methods of making and using thereof.
|
|
|
6962717 |
Pharmaceutical compositions
A pharmaceutical composition for slow release of active ingredient in the gastrointestinal tract, comprising a plurality of active ingredient-containing particles coated with a material insoluble...
|
|
|
6958161 |
Modified release coated drug preparation
A modified release preparation having one or more coated core elements, each core element including an active ingredient and having a modified release coating, wherein a stabilising coat is...
|
|
|
6956043 |
Pharmaceutical compositions comprising 33-epi-chloro-33-desoxy-ascomycin solid dispersions
A pharmaceutical composition in the form of a solid dispersion comprising a macrolide, e.g. a rapamycin or an ascomycin, and a carrier medium.
|